수면 보조제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 유형별, 수면장애별, 유통 채널별, 지역별, 경쟁별(2020-2030년)
Sleeping Aids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,egmented By Product Type, By Sleep Disorder, By Distribution Channel, By Region and Competition, 2020-2030F
상품코드:1878930
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 187 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 수면 보조제 시장은 2024년에 665억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 6.45%로 성장하여 967억 9,000만 달러에 달할 것으로 예측됩니다.
수면 보조제는 수면의 질을 개선하고 다양한 수면 장애를 해결하기 위해 고안된 의약품, 보충제, 전용 기기 등 다양한 의약품 및 비의약품 제품 및 요법을 포함합니다. 시장 확대는 주로 전 세계적으로 수면 장애의 유병률 증가와 수면 건강에 대한 인식이 높아짐에 따라 주도되고 있습니다. 세계 인구의 고령화, 증가하는 스트레스 수준, 그리고 변화하는 라이프스타일이 이러한 장애에 크게 기여하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
665억 2,000만 달러
시장 규모 : 2030년
967억 9,000만 달러
CAGR : 2025-2030년
6.45%
가장 빠르게 성장하는 부문
병원 약국
최대 시장
북미
주요 시장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 수면 보조제 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제품 유형별(매트리스·베개, 의약품, 수면무호흡증 치료 기기, 기타)
수면장애별(불면증, 기면증, 하지불안증후군, 수면무호흡증, 기타)
유통 채널별(병원 약국, 소매 약국, E-Commerce, 드럭스토어, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 수면 보조제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 수면 보조제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 수면 보조제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 수면 보조제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 수면 보조제 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 수면 보조제 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
AstraZeneca Plc
BMC Medical Co., Ltd.
Cadwell Industries, Inc
Compumedics Limited
Drive DeVilbiss Healthcare Inc
Eisai Co. Ltd.
Fisher & Paykel Healthcare Limited
GlaxoSmithKline Plc
Idorsia Pharmaceuticals Ltd
Koninklijke Philips N.V
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Sleeping Aids Market, valued at USD 66.52 Billion in 2024, is projected to experience a CAGR of 6.45% to reach USD 96.79 Billion by 2030. Sleeping aids encompass a broad spectrum of pharmaceutical and non-pharmaceutical products and therapies designed to enhance sleep quality and address various sleep disorders, including medications, supplements, and specialized devices. The market's expansion is primarily driven by the escalating global prevalence of sleep disorders and a growing awareness of sleep health. An aging global population, increasing stress levels, and changing lifestyles contribute significantly to these disorders.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 66.52 Billion
Market Size 2030
USD 96.79 Billion
CAGR 2025-2030
6.45%
Fastest Growing Segment
Hospital Pharmacies
Largest Market
North America
Key Market Drivers
The increased prevalence of sleep disorders significantly drives the global sleeping aids market. As populations contend with conditions such as insomnia and sleep apnea, demand for effective diagnostic tools and therapeutic interventions grows. For instance, according to a survey commissioned by the American Academy of Sleep Medicine, in June 2024, 12% of Americans reported a diagnosis of chronic insomnia, highlighting a substantial segment of the population seeking relief.
Key Market Challenges
A significant challenge impeding market expansion in the Global Sleeping Aids Market is the ongoing concern regarding the potential side effects and dependency risks associated with certain prescription sleep medications. This apprehension directly influences consumer behavior, often leading individuals to prefer non-pharmacological alternatives or to discontinue treatment. This reluctance to use or continue prescription sleep aids directly hampers market growth in specific product segments. For instance, according to the American Academy of Sleep Medicine's 2024 Sleep in America poll, 38% of adults who experience sleep difficulties reported actively avoiding prescription sleep medication due to worries about potential side effects or addiction. This consumer shift limits sustained market expansion for pharmaceutical solutions, as a substantial portion of the target demographic opts for perceived safer options. The market consequently experiences constrained growth in segments reliant on prescription sales, impacting overall adoption rates and the potential for greater market penetration.
Key Market Trends
The increasing consumer preference for natural and herbal sleep aids is significantly reshaping the global sleeping aids market. Consumers are increasingly seeking alternatives to traditional pharmaceutical options, driven by concerns about potential side effects and dependency risks associated with prescription medications. This shift is expanding the market beyond conventional offerings toward botanical and supplement-based solutions. According to the Council for Responsible Nutrition 2024 Consumer Survey, published in October 2024, magnesium usage among supplement users rose from 19% in 2023 to 23% in 2024, while ashwagandha use increased from 2% in 2020 to 8% in 2024, reflecting growing interest in ingredients often found in natural sleep aids. This rising demand encourages innovation and product development in the natural segment. For instance, in May 2024, Natrol, a prominent melatonin brand, introduced Time Release Melatonin gummies, designed for dual-action delivery to assist with both falling and staying asleep, catering to this evolving consumer preference.
Key Market Players
AstraZeneca Plc
BMC Medical Co., Ltd.
Cadwell Industries, Inc
Compumedics Limited
Drive DeVilbiss Healthcare Inc
Eisai Co. Ltd.
Fisher & Paykel Healthcare Limited
GlaxoSmithKline Plc
Idorsia Pharmaceuticals Ltd
Koninklijke Philips N.V
Report Scope:
In this report, the Global Sleeping Aids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Sleeping Aids Market, By Product Type:
Mattresses & Pillows
Medications
Sleep Apnea Devices
Others
Sleeping Aids Market, By Sleep Disorder:
Insomnia
Narcolepsy
Restless Leg Syndrome
Sleep Apnea
Others
Sleeping Aids Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
E-commerce
Drug Stores
Others
Sleeping Aids Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Sleeping Aids Market.
Available Customizations:
Global Sleeping Aids Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Sleeping Aids Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Mattresses & Pillows, Medications, Sleep Apnea Devices, Others)
5.2.2. By Sleep Disorder (Insomnia, Narcolepsy, Restless Leg Syndrome, Sleep Apnea, Others)
5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce, Drug Stores, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Sleeping Aids Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Sleep Disorder
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Sleeping Aids Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Sleep Disorder
6.3.1.2.3. By Distribution Channel
6.3.2. Canada Sleeping Aids Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Sleep Disorder
6.3.2.2.3. By Distribution Channel
6.3.3. Mexico Sleeping Aids Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Sleep Disorder
6.3.3.2.3. By Distribution Channel
7. Europe Sleeping Aids Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Sleep Disorder
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Sleeping Aids Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Sleep Disorder
7.3.1.2.3. By Distribution Channel
7.3.2. France Sleeping Aids Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Sleep Disorder
7.3.2.2.3. By Distribution Channel
7.3.3. United Kingdom Sleeping Aids Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Sleep Disorder
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Sleeping Aids Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Sleep Disorder
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Sleeping Aids Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Sleep Disorder
7.3.5.2.3. By Distribution Channel
8. Asia Pacific Sleeping Aids Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Sleep Disorder
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Sleeping Aids Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Sleep Disorder
8.3.1.2.3. By Distribution Channel
8.3.2. India Sleeping Aids Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Sleep Disorder
8.3.2.2.3. By Distribution Channel
8.3.3. Japan Sleeping Aids Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Sleep Disorder
8.3.3.2.3. By Distribution Channel
8.3.4. South Korea Sleeping Aids Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Sleep Disorder
8.3.4.2.3. By Distribution Channel
8.3.5. Australia Sleeping Aids Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Sleep Disorder
8.3.5.2.3. By Distribution Channel
9. Middle East & Africa Sleeping Aids Market Outlook
